Home › Stocks › CTSO › All Fund Holders
CTSO — CYTOSORBENTS CORP · All Fund Holders
Funds holding (latest): 29 · Reported value held: $3.42M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 2.20M | $1.41M | 0.00% | Hold |
| Royce & Associates history | Q2 2022 | 349.00K | $764.00K | 0.01% | Hold |
| BlackRock Inc history | Q2 2026 | 627.21K | $234.58K | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 602.06K | $225.24K | 0.00% | Reduce |
| AQR Capital Management history | Q4 2021 | 40.44K | $169.00K | 0.00% | Add |
| Two Sigma Investments history | Q4 2021 | 33.31K | $140.00K | 0.00% | Add |
| Manulife Financial history | Q1 2022 | 20.39K | $65.00K | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2023 | 17.68K | $63.48K | 0.00% | Hold |
| UBS Group AG history | Q2 2026 | 131.02K | $49.00K | 0.00% | Add |
| Invesco Ltd history | Q1 2022 | 13.91K | $44.00K | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 111.66K | $41.76K | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 100.02K | $37.41K | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 91.34K | $34.16K | 0.00% | Reduce |
| Marshall Wace history | Q4 2021 | 7.63K | $31.00K | 0.00% | New |
| Balyasny Asset Management history | Q2 2022 | 11.76K | $26.00K | 0.00% | New |
| Prudential Financial history | Q3 2024 | 14.80K | $22.20K | 0.00% | New |
| Charles Schwab Investment Management history | Q4 2023 | 15.99K | $17.75K | 0.00% | Hold |
| Bank of America Corp history | Q2 2026 | 38.69K | $14.47K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2022 | 3.18K | $7.00K | 0.00% | Reduce |
| Millennium Management history | Q4 2025 | 10.21K | $6.52K | 0.00% | New |
| Goldman Sachs Group history | Q2 2026 | 15.34K | $5.74K | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 14.40K | $5.39K | 0.00% | Add |
| BNY Mellon history | Q1 2024 | 3.64K | $3.46K | 0.00% | Reduce |
| Citigroup Inc history | Q2 2022 | 420 | $1.00K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q4 2025 | 384 | $245 | 0.00% | New |
| JPMorgan Chase & Co history | Q2 2026 | 372 | $142 | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 250 | $94 | 0.00% | Hold |
| PNC Financial Services history | Q2 2026 | 31 | $12 | 0.00% | Hold |
| Lazard Asset Management history | Q1 2025 | 954 | $0 | — | New |